Antiangiogenic Activity of Semisynthetic Biotechnological Heparins: Low-Molecular-Weight–Sulfated Escherichia coli K5 Polysaccharide Derivatives as Fibroblast Growth Factor Antagonists

OBJECTIVE—Low-molecular-weight heparin (LMWH) exerts antitumor activity in clinical trials. The K5 polysaccharide from Escherichia coli has the same structure as the heparin precursor. Chemical and enzymatic modifications of K5 polysaccharide lead to the production of biotechnological heparin-like c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2005-01, Vol.25 (1), p.71-76
Hauptverfasser: Presta, Marco, Oreste, Pasqua, Zoppetti, Giorgio, Belleri, Mirella, Tanghetti, Elena, Leali, Daria, Urbinati, Chiara, Bugatti, Antonella, Ronca, Roberto, Nicoli, Stefania, Moroni, Emanuela, Stabile, Helena, Camozzi, Maura, Hernandez, German Andrés, Mitola, Stefania, Dell’Era, Patrizia, Rusnati, Marco, Ribatti, Domenico
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!